相似文献
1
Most drugs paid for by £1.27bn Cancer Drugs Fund had no "meaningful benefit".
BMJ. 2017 Apr 28;357:j2097. doi: 10.1136/bmj.j2097.
2
New Cancer Drugs Fund is flawed without NICE reform, says Roche.
BMJ. 2016 Jul 29;354:i4216. doi: 10.1136/bmj.i4216.
3
At last, NICE to take over the Cancer Drugs Fund.
BMJ. 2016 Mar 7;352:i1324. doi: 10.1136/bmj.i1324.
4
Careful use of science to advance the debate on the UK Cancer Drugs Fund.
JAMA. 2014 Jan 1;311(1):25-6. doi: 10.1001/jama.2013.282839.
5
UK Cancer Drugs Fund to reassess 42 agents.
Lancet Oncol. 2015 Jan;16(1):e8. doi: 10.1016/S1470-2045(14)71137-4. Epub 2014 Nov 21.
6
Cancer Drugs Fund of minimal benefit.
Lancet Oncol. 2017 Jun;18(6):e305. doi: 10.1016/S1470-2045(17)30322-4. Epub 2017 May 5.
7
Pfizer to make palbociclib temporarily free on NHS.
Lancet Oncol. 2017 Jun;18(6):e309. doi: 10.1016/S1470-2045(17)30343-1. Epub 2017 May 11.
8
Five cancer drugs back on NHS list after deals with drug companies.
BMJ. 2015 Nov 5;351:h5985. doi: 10.1136/bmj.h5985.
9
New NICE criteria for drug access.
Lancet Oncol. 2017 May;18(5):576. doi: 10.1016/S1470-2045(17)30235-8. Epub 2017 Mar 23.
10
Cancer charity demands extension of drug fund despite criticisms it is unfair.
BMJ. 2014 Oct 28;349:g6507. doi: 10.1136/bmj.g6507.
引用本文的文献
1
Do cancer drugs improve survival or quality of life?
BMJ. 2017 Oct 4;359:j4528. doi: 10.1136/bmj.j4528.
Zotero 插件